ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammer Okay, Panel’s Pittsburgh Meeting Rescheduled For Oc 23; Campbell Leaves AICR

July 17, 1987

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

AIDS Vaccine Intervention Progress Reported

July 5, 1985

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000